Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3732239rdf:typepubmed:Citationlld:pubmed
pubmed-article:3732239lifeskim:mentionsumls-concept:C0019944lld:lifeskim
pubmed-article:3732239lifeskim:mentionsumls-concept:C0026995lld:lifeskim
pubmed-article:3732239lifeskim:mentionsumls-concept:C0022026lld:lifeskim
pubmed-article:3732239pubmed:issue3lld:pubmed
pubmed-article:3732239pubmed:dateCreated1986-9-16lld:pubmed
pubmed-article:3732239pubmed:abstractTextThe use of the non-ionic, water-soluble contrast agent iopamidol for myelography in seven horses is described. Contrast columns of diagnostic quality were produced in all seven cases and the procedure did not invoke any adverse reactions in the five cases which were recovered from general anaesthesia. It is concluded that iopamidol is a safe and effective contrast agent for myelography in the horse.lld:pubmed
pubmed-article:3732239pubmed:languageenglld:pubmed
pubmed-article:3732239pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3732239pubmed:citationSubsetIMlld:pubmed
pubmed-article:3732239pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3732239pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3732239pubmed:statusMEDLINElld:pubmed
pubmed-article:3732239pubmed:monthMaylld:pubmed
pubmed-article:3732239pubmed:issn0425-1644lld:pubmed
pubmed-article:3732239pubmed:authorpubmed-author:JonesR SRSlld:pubmed
pubmed-article:3732239pubmed:authorpubmed-author:Wyn-JonesGGlld:pubmed
pubmed-article:3732239pubmed:authorpubmed-author:LIUP YPYlld:pubmed
pubmed-article:3732239pubmed:authorpubmed-author:ChurchSSlld:pubmed
pubmed-article:3732239pubmed:authorpubmed-author:BrouwerG JGJlld:pubmed
pubmed-article:3732239pubmed:issnTypePrintlld:pubmed
pubmed-article:3732239pubmed:volume18lld:pubmed
pubmed-article:3732239pubmed:ownerNLMlld:pubmed
pubmed-article:3732239pubmed:authorsCompleteYlld:pubmed
pubmed-article:3732239pubmed:pagination199-202lld:pubmed
pubmed-article:3732239pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:3732239pubmed:meshHeadingpubmed-meshheading:3732239-...lld:pubmed
pubmed-article:3732239pubmed:meshHeadingpubmed-meshheading:3732239-...lld:pubmed
pubmed-article:3732239pubmed:meshHeadingpubmed-meshheading:3732239-...lld:pubmed
pubmed-article:3732239pubmed:meshHeadingpubmed-meshheading:3732239-...lld:pubmed
pubmed-article:3732239pubmed:meshHeadingpubmed-meshheading:3732239-...lld:pubmed
pubmed-article:3732239pubmed:meshHeadingpubmed-meshheading:3732239-...lld:pubmed
pubmed-article:3732239pubmed:meshHeadingpubmed-meshheading:3732239-...lld:pubmed
pubmed-article:3732239pubmed:meshHeadingpubmed-meshheading:3732239-...lld:pubmed
pubmed-article:3732239pubmed:meshHeadingpubmed-meshheading:3732239-...lld:pubmed
pubmed-article:3732239pubmed:year1986lld:pubmed
pubmed-article:3732239pubmed:articleTitleIopamidol myelography in the horse.lld:pubmed
pubmed-article:3732239pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3732239pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed